发明名称 COMBINATIONS FOR TREATING MULTIPLE MYELOMA
摘要 <p>Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed. In a specific embodiment, the cancer is lymphoma.</p>
申请公布号 PT1505973(E) 申请公布日期 2010.05.21
申请号 PT20030728969T 申请日期 2003.05.16
申请人 CELGENE CORPORATION 发明人 JEROME B. ZELDIS
分类号 A61K31/454;A61K45/00;A61K31/00;A61K31/198;A61K31/40;A61K31/4035;A61K31/425;A61K31/445;A61K31/475;A61K31/515;A61K31/573;A61K31/704;A61K35/12;A61K35/14;A61K35/28;A61K45/06;A61K51/00;A61P1/04;A61P1/16;A61P3/06;A61P3/10;A61P7/02;A61P7/06;A61P9/00;A61P9/04;A61P9/10;A61P9/14;A61P11/00;A61P11/06;A61P11/16;A61P17/00;A61P17/02;A61P17/06;A61P17/10;A61P17/12;A61P19/02;A61P19/08;A61P19/10;A61P25/00;A61P27/02;A61P27/06;A61P27/10;A61P27/14;A61P29/00;A61P31/00;A61P31/04;A61P31/08;A61P31/10;A61P31/12;A61P31/18;A61P31/22;A61P33/00;A61P33/02;A61P33/06;A61P35/00;A61P35/02;A61P35/04;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P41/00;A61P43/00;C07D209/46;C07D401/04;C07J5/00 主分类号 A61K31/454
代理机构 代理人
主权项
地址